Skip to main content
Equibles
INVA logo

INVA · Innoviva, Inc. · Metrics

Track INVA — free

Use INVA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research INVA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$20.66 -0.40 (-1.90%) At close · Oct 23
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.49B
Shares
72.25M
Volume · Oct 23 978.57K Avg daily vol (3M) 770.82K

INVA metrics

96 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$20.66
Market cap
$1.49B

Price action

20 metrics
Price change (1W)
-0.6%
Price change (30D)
+0.0%
Price change (3M)
-3.6%
Price change (6M)
-12.3%
Price change (YTD)
+3.4%
Price change (1Y)
+13.1%
Trailing year
Price change (5Y)
+27.2%
52-week high
$24.24
52-week low
$17.57
Change from 52-week high
-14.8%
Change from 52-week low
+17.6%
Annualized volatility
27.3%
Annualized volatility (3M)
22.7%
Beta
0.0
RSI (14D)
45.5
Price vs SMA 50
-1.6%
Price vs SMA 200
-5.4%
Avg volume (3M)
770,824
Relative volume
1.3
Average dollar volume
$16.13M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
72.25M

Valuation

12 metrics
P / E (TTM)
4.7
Trailing earnings · reciprocal yield 21.1%
PEG ratio
—
EV / revenue
2.8×
reciprocal yield 35.8%
EV / EBITDA
4.8×
reciprocal yield 21.0%
EV / EBIT
7.6×
reciprocal yield 13.2%
P / sales
3.5×
reciprocal yield 28.9%
P / book
1.2
reciprocal yield 81.1%
FCF yield
12.5%
TTM · current market cap
Buyback yield
3.7%
P / FCF
8.0
reciprocal yield 12.5%
P / operating cash flow
7.9
reciprocal yield 12.6%
Earnings yield
23.5%

Historical valuation

8 metrics
P / E historical average (3Y)
14.4×
reciprocal yield 7.0%
P / E historical average (5Y)
10.4×
reciprocal yield 9.6%
EV / revenue historical average (3Y)
3.6×
reciprocal yield 28.1%
EV / revenue historical average (5Y)
3.5×
reciprocal yield 28.5%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
5.2×
reciprocal yield 19.3%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2024-05-08

Profitability

9 metrics
Gross margin
72.2%
Operating margin
36.9%
Trailing 12 months
Net margin
81.2%
Gross profit (TTM)
$317.65M
Operating profit (TTM)
$162.57M
Net income (TTM)
$357.24M
Trailing 12 months
Diluted EPS (TTM)
$4.35
FCF margin
43.1%
Effective tax rate
14.8%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
$4.29
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$15.71

Growth

11 metrics
Revenue growth YoY
+19.3%
Year over year
Net income growth YoY
-231.0%
Revenue (TTM)
$440.00M
Trailing 12 months
EPS growth YoY
-248.1%
Shares change YoY
-13.1%
Year over year · fewer shares
Revenue CAGR (3Y)
+7.5%
Revenue CAGR (5Y)
+4.1%
EPS CAGR (3Y)
+11.7%
EPS CAGR (5Y)
+10.3%
FCF CAGR (3Y)
-1.0%
FCF CAGR (5Y)
-9.0%

Quality

14 metrics
Return on equity
29.0%
Return on assets
21.0%
Debt / equity
0.2
Current ratio
16.0
EBITDA (TTM)
$373.37M
Free cash flow (TTM)
$189.44M
Quick ratio
15.2
Interest coverage
8.9
Net debt / EBITDA
0.7
Return on invested capital
15.7%
Trailing 12 months
Net cash
$293.21M
Latest balance sheet
Cash & equivalents
$570.39M
Total assets
$1.70B
Total debt
$257.73M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$191.49M
Capital expenditures (TTM)
$2.05M
R&D (TTM)
$28.66M
SG&A (TTM)
$126.42M
Stock compensation (TTM)
$12.19M
R&D / revenue
6.5%
Stock compensation / revenue
2.8%

Ownership (13F)

9 metrics
13F filers
309
13F filer change QoQ
+23
Institutional ownership
103.3%
Conviction holders (share of 13F filers)
0.3%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-3.0%
Holder tenure
16.5
Price vs estimated holder cost
+17.9%

Ownership (registered funds)

1 metrics
Index-fund ownership
31.3%

Short interest

3 metrics
Short interest
9.5%
Latest settlement · 5.7 days to cover
Days to cover
5.7d
Short-squeeze score
69 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1080014 CUSIP 45781M101 13F (30d) 41 filings 41 filers Visit website Investor relations